MSK Department of Medicine
@mskdeptofmed.bsky.social
250 followers 130 following 120 posts
The official account of @mskcancercenter.bsky.social's Department of Medicine. Chair/Dept. Head: Deb Schrag
Posts Media Videos Starter Packs
Reposted by MSK Department of Medicine
vjhemonc.bsky.social
🎥 At #SOHO2025, Ariela Noy of @mskcancercenter.bsky.social shared insights into the management of Burkitt #lymphoma, highlighting the need to improve frontline treatment.

Watch here:
👉 buff.ly/kp1MrVH 👈

#LYMsm #Lymphoma #HemOnc #BloodSky #HemeSky #MedSky @societyofhemonc.bsky.social
Reposted by MSK Department of Medicine
mskcancercenter.bsky.social
Join us for MSK's 2025 Health Equity in Cancer Care Conference on Friday, November 14. This complimentary one-day event will unite experts from across fields, institutions, and specialties to explore actionable strategies for advancing #healthequity in underserved populations.
Reposted by MSK Department of Medicine
mskcancercenter.bsky.social
Cancer research means bigger breakthroughs, on a faster timeline, that improve the lives of people impacted by cancer. Today is World Cancer Research Day & all donations will be DOUBLED.

Donate today & help bring more possibilities to families facing cancer. bit.ly/46mefYy #WorldCancerResearchDay
Reposted by MSK Department of Medicine
mskcancercenter.bsky.social
Radiation therapy for prostate cancer is more precise, convenient, and personalized than ever before. From #SBRT to MRI-guided and adaptive approaches, MSK experts are leading advances that improve outcomes and protect quality of life for patients with #prostatecancer. ⬇️
The Latest Radiation Therapy for Prostate Cancer: What Every Man Should Know
It can be hard to understand all the various radiation therapy options for prostate cancer. Here, we explain.
www.mskcc.org
mskdeptofmed.bsky.social
At #IMS25, Dr. Francesco Maura will present new research on the genomics that define neoplastic transformation in #multiplemyeloma precursor conditions. #mmsm

🗓️ Saturday, September 20 | 9:20 a.m. EDT

@mskcancercenter.bsky.social @myeloma-society.bsky.social @szusmani.bsky.social
mskdeptofmed.bsky.social
Coming up at #IMS25: Join MSK's Myeloma Service Chief @szusmani.bsky.social to learn about current challenges in #multiplemyeloma relapse & future research needed to overcome them. #mmsm

🗓️ Friday, September 19 | 9:40 a.m. EDT

@mskcancercenter.bsky.social @myeloma-society.bsky.social
mskdeptofmed.bsky.social
Coming up at #IMS25: Dr. Sham Mailankody will share the results of a phase 1 clinical trial of concurrent BCMA and GPRC5D #CARTcells for relapsed/refractory #multiplemyeloma.

🗓️ Thursday, September 18 | 4:40 p.m. EDT

@mskcancercenter.bsky.social @szusmani.bsky.social @myeloma-society.bsky.social
mskdeptofmed.bsky.social
At #IMS25, Dr. Carlyn Tan will share new data on early mortality associated with real-world bispecific antibody therapy for relapsed/refractory #multiplemyeloma.

🗓️ Wednesday, September 17 | 12:14 p.m. EDT

@mskcancercenter.bsky.social @szusmani.bsky.social @myeloma-society.bsky.social
mskdeptofmed.bsky.social
MSK experts have arrived at #IMS25! Join Dr. Francesco Maura to learn about genomic drivers of resistance to anti-BCMA immunotherapies in #multiplemyeloma. #mmsm

🗓️ Wednesday, September 17 | 11:10 a.m. EDT

@mskcancercenter.bsky.social @szusmani.bsky.social @myeloma-society.bsky.social
mskdeptofmed.bsky.social
MSK is headed to Toronto for #IMS25! Stay tuned for posters and presentations that are advancing #multiplemyeloma research and treatments. #mmsm

@mskcancercenter.bsky.social @szusmani.bsky.social @myeloma-society.bsky.social
myeloma-society.bsky.social
⏳We are less than one week away from #IMS25 in Toronto! Get ready for world-class insights, valuable networking, and meaningful innovation. If you can’t join us in person, you can still take part virtually. 💻 Register now ➡️ rb.gy/139j28
mskdeptofmed.bsky.social
Starting TODAY! Join @greatdebates.bsky.social
and Yelena Janjigian, Chief of the MSK Gastrointestinal Oncology Service, to learn about the latest treatments for #gastriccancer and #colorectalcancer.

@mskcancercenter.bsky.social #crcsm #GIcancer

See the full agenda 📖: bit.ly/48g13pf
mskdeptofmed.bsky.social
🚨 Happening Soon: @mskcancercenter.bsky.social's Eileen O'Reilly and @mayocliniccancer.bsky.social's Tanios Bekaii-Saab will kick off #ISGIO2025! Join them for opening remarks as program chairs at 9 a.m. CDT/10 a.m. EDT. #GICSM

See the agenda for a full lineup of MSK experts: bit.ly/3JSTg6V
Dr. Eileen O'Reilly is sitting smiling in a white lab coat.
Reposted by MSK Department of Medicine
mskcancercenter.bsky.social
Happening Tuesday, 9/9 at #WCLC25: MSK's Dr. Alexis Chidi will discuss how deep learning-based CT analysis enhances #lungcancer risk prediction in never smoking women. Follow along for coverage of the latest advances. #LCSM #SCLC @iaslc.bsky.social

Tuesday, 9/9 | 10 a.m. CEST

More: bit.ly/45XeCZq
Reposted by MSK Department of Medicine
mskcancercenter.bsky.social
Happening Tuesday, 9/9 at #WCLC25: MSK's Dr. David Jones will discuss perioperative modalities for resectable non small cell #lungcancer. Follow along for coverage of the latest advances. #LCSM #SCLC @iaslc.bsky.social l

Tuesday, 9/9 | 1 p.m. CEST

Learn more: bit.ly/3V3O8iD
mskdeptofmed.bsky.social
We're counting down the days until #ASH25 in December! ⏰Don't miss the scientific workshops taking place on the Friday before the meeting. @ash.hematology.org @mskcancercenter.bsky.social
ash.hematology.org
Did you know the Scientific Workshops at #ASH25, taking place Friday before the meeting, are included in your meeting registration?

Make connections and share your work!

Learn more about the topics: https://bit.ly/4m8HymN #Hemesky #MedSky
mskdeptofmed.bsky.social
At #WCLC25, our #RadOnc colleague Jennifer Ma will present a retrospective review of intrathoracic radiotherapy to treat #HPV-associated head and neck #squamouscellcarcinoma metastases. #LCSM @iaslc.bsky.social @mskcancercenter.bsky.social

September 9 | 3 p.m. CEST

➡️ bit.ly/4mUWZ2m
mskdeptofmed.bsky.social
Tomorrow morning, #lungcancer expert Mark Kris will discuss clinicopathologic features of TP53/RB1-mutant squamous cell lung cancers at #WCLC25. #LCSM @iaslc.bsky.social @mskcancercenter.bsky.social

September 8 | 10:30 a.m.. CEST

➡️ bit.ly/41EZM7b
mskdeptofmed.bsky.social
Coming up at #WCLC25: @mskcancercenter.bsky.social's Helena Yu will highlight diagnostic and treatment opportunities for #leptomeningealdisease in oncogene-driven non-small cell #lungcancer. #LCSM @iaslc.bsky.social

September 7 | 3:53 p.m. CEST

➡️ bit.ly/4mOHBnV
mskdeptofmed.bsky.social
Don't miss an opportunity to learn from the Chief of the Thoracic Oncology Service at @mskcancercenter.bsky.social! At #WCLC25, Mark Awad will share lessons about work-life balance in high-stress medical careers. #LCSM @iaslc.bsky.social

September 7 | 1:45 p.m. CEST

➡️ bit.ly/3HTNpxr
Reposted by MSK Department of Medicine
mskcancercenter.bsky.social
Happening Monday, 9/8 at #WCLC25: MSK pathologist Dr. Natasha Rekhtman will discuss optimizing front-line treatment for small cell #lung cancer. Follow along for coverage of the latest advances. #LCSM #SCLC @iaslc.bsky.social

📆: September 8 at 5 p.m. CEST

Learn more: bit.ly/4mXBiig
Reposted by MSK Department of Medicine
mskcancercenter.bsky.social
Out now in @cp-trendsbiochem.bsky.social: "PTMs as Molecular Encoders: Reprogramming Chaperones into Epichaperomes for Network Control in Disease" from @chiosislabmskcc.bsky.social. Learn more ⬇️
cp-trendsbiochem.bsky.social
📝 Online now - the Review "PTMs as molecular encoders: reprogramming chaperones into epichaperomes for network control in disease" from @chiosislabmskcc.bsky.social et al.

#ProteinProteinInteractions #ProteinNetworks #ChaperoneReprogramming

Read it here 👉 authors.elsevier.com/sd/article/S...
mskdeptofmed.bsky.social
Happening tomorrow at #WCLC25: @mskcancercenter.bsky.social's @charlesrudin.bsky.social will highlight future directions in small cell #lungcancer research. Follow along for coverage of the latest advances. #LCSM #SCLC @iaslc.bsky.social

September 6 | 10:30 a.m. CEST

➡️ bit.ly/3HJJmnp
Charles Rudin looks at the camera in a white lab coat.
Reposted by MSK Department of Medicine
mskcancercenter.bsky.social
At MSK, Clinical Nurse Specialists (CNS) are making a significant impact on patient outcomes through their expert guidance, evidence-based interventions, & compassionate leadership.

This #CNSWeek, we honor their dedication to advancing care and improving lives. Help celebrate our MSK CNSs below! 🎉
mskdeptofmed.bsky.social
Results of a pilot study led by investigators at @mskcancercenter.bsky.social showed that interleukin-18 “armored” CAR T cells targeting CD371 were effective at treating relapsed/refractory acute myeloid #leukemia at low doses. @markgeyermd.bsky.social
Learn more: bit.ly/4mFwo9q
mskdeptofmed.bsky.social
Congrats to Rastko Rakočević of the Pulmonary Service on receiving a certificate of excellence for presenting a top abstract in a plenary session at #AABIP2025! He presented research on robotic-assisted #bronchoscopy for biopsy of primary #lungcancers. @mskcancercenter.bsky.social
Photo of Rastko Rakočević holding his certificate at the conference.